Sequence-specific 1H and 15N resonance assignments for human dihydrofolate reductase in solution.
Article Details
- CitationCopy to clipboard
Stockman BJ, Nirmala NR, Wagner G, Delcamp TJ, DeYarman MT, Freisheim JH
Sequence-specific 1H and 15N resonance assignments for human dihydrofolate reductase in solution.
Biochemistry. 1992 Jan 14;31(1):218-29.
- PubMed ID
- 1731871 [ View in PubMed]
- Abstract
Dihydrofolate reductase is an intracellular target enzyme for folate antagonists, including the anticancer drug methotrexate. In order to design novel drugs with altered binding properties, a detailed description of protein-drug interactions in solution is desirable to understand the specificity of drug binding. As a first step in this process, heteronuclear three-dimensional NMR spectroscopy has been used to make sequential resonance assignments for more than 90% of the residues in human dihydrofolate reductase complexed with methotrexate. Uniform enrichment of the 21.5-kDa protein with 15N was required to obtain the resonance assignments via heteronuclear 3D NMR spectroscopy since homonuclear 2D spectra did not provide sufficient 1H resonance dispersion. Medium- and long-range NOE's have been used to characterize the secondary structure of the binary ligand-enzyme complex in solution.